| Symbol | FLGT |
|---|---|
| Name | FULGENT GENETICS, INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Medical Specialities |
| Address | 4978 SANTA ANITA AVENUE,SUITE 205, TEMPLE CITY, California, 91780, United States |
| Telephone | +1 626 350-0537 |
| Fax | — |
| — | |
| Website | https://www.fulgentgenetics.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001674930 |
| Description | Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. Genetic testing offers the possibility of early identification of a disease or a genetic predisposition to disease and enhanced disease treatment and prognosis. Fulgents product portfolio includes Genes & Panels, Known Mutation, Genomic Testing, Hereditary Cancer, Carrier Screening, Tumor Profiling, and Sequencing Service. Its customers are categorized as Insurance; Institutional, which includes hospitals, medical institutions, laboratories, governmental bodies, municipalities, and large corporations; and Patients. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign. Additional info from NASDAQ: |
Foundation Medicine to Launch FoundationOne®PGx, a Pharmacogenetic Offering, Through Expanded Partnership with Fulgent Genetics
Read moreGao Hanlin 🔴 sold 1.6K shares of Fulgent Genetics, Inc. (FLGT) at $16.31 Transaction Date: Apr 26, 2026 | Filing ID: 187451
Read moreXie Jian 🔴 sold 4.4K shares of Fulgent Genetics, Inc. (FLGT) at $16.31 Transaction Date: Apr 26, 2026 | Filing ID: 187448
Read moreKim Paul 🔴 sold 2.7K shares of Fulgent Genetics, Inc. (FLGT) at $16.31 Transaction Date: Apr 26, 2026 | Filing ID: 187445
Read moreFulgent to Announce First Quarter 2026 Financial Results on Friday, May 1, 2026
Read moreNew Form 4/A - Fulgent Genetics, Inc. <b>Filed:</b> 2026-03-31 <b>AccNo:</b> 0001302110-26-000014 <b>Size:</b> 13 KB
Read moreNew Form SCHEDULE 13D/A - Fulgent Genetics, Inc. <b>Filed:</b> 2026-03-31 <b>AccNo:</b> 0001302110-26-000013 <b>Size:</b> 23 KB
Read moreFLGT INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Fulgent Genetics Inc.
Read moreFULGENT GENETICS INC. INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud
Read more